UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Details
Sales, net	$ 12,604	$ 8,787	$ 23,568	$ 19,689
Cost of goods sold	4,819	3,837	8,836	7,903
Gross profit	7,785	4,950	14,732	11,786
Operating expense
Selling, general and administrative	2,892	2,857	5,821	5,696
Research & development	128	116	259	250
Total operating expenses	3,020	2,973	6,080	5,946
Operating income	4,765	1,977	8,652	5,840
Other income	60	0	71	125
Income before provision for income taxes	4,825	1,977	8,723	5,965
Provision for income taxes	1,399	664	2,273	1,513
Net income	$ 3,426	$ 1,313	$ 6,450	$ 4,452
Earnings per common share (basic)	$ 0.94	$ 0.36	$ 1.77	$ 1.21
Earnings per common share (diluted)	$ 0.94	$ 0.36	$ 1.76	$ 1.21
Shares outstanding - basic	3,646	3,643	3,645	3,675
Shares outstanding - diluted	3,655	3,659	3,656	3,690
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 49	$ 522	$ (5)	$ (1,927)
Total comprehensive income	$ 3,475	$ 1,835	$ 6,445	$ 2,525